Evidera’s Post

Great presentation from eclevar medtech Japan team around how to gather clinical data using survey and how to identify patient and hospitals for your pmcf activity

Immerse yourself in our on-demand webinar as we unravel the intricacies of trial design. Discover the delicate balance between safety and efficacy demands, influencing patient selection and transforming care. Industry experts share their insights into the complexities of developing groundbreaking treatments and the pivotal equilibrium within clinical trials. Register now to deepen your understanding of the dynamic world of clinical data analysis: https://ow.ly/haX730sA8AM #ClinicalDataAnalysis #TrialDesign #HealthcareInnovation

While decentralized trials are transforming the clinical trial landscape, enabling broader patient participation and ultimately paving a faster road to market, concerns about participant adherence are at the forefront. Learn how new approaches are helping to mitigate these uncertainties, with solutions for enabling more effective decentralized trials. Access the whitepaper in partnership with Thermo Fisher Scientific: https://ow.ly/B8Za50RNJyS. #ClinicalTrialLandscape #PatientParticipation #DecentralizedApproaches #DecentralizedTrials #HealthcareInnovation #EffectiveTrials #ClinicalResearch

Are you ready to conquer the complexities of market access in healthcare? Dive into our latest blog co-authored by Nicole Ferko, General Manager, Value and Evidence, Tim Healey, Chief Commercial Officer and Megan Bourque, Director, Value & Evidence. Discover top considerations for effective evidence generation, from engaging decision-makers early to fostering cross-functional collaboration. Equip your team with the insights needed for market success! https://ow.ly/lbSn50QFpz9

What are the major factors driving world healthcare dynamics? How they are impacting the overall landscape for clinical trials worldwide? Download your free report in partnership with IQVIA to find out: https://ow.ly/175R50SpqrZ. #HealthcareDynamics #ClinicalTrials #IQVIA #PharmaIndustry

Biorasi believes that by listening to the voice of patient #diversity and implementing #FDA guidance measures, clinical study stakeholders can improve trust, engagement, and patient outcomes. Find out more in our latest white paper: Patient Diversity in #ClinicalResearch >> https://bit.ly/4biLdZc

Early-phase oncology clinical trials are becoming increasingly complex. Despite these complexities, IQVIA Biotech Australia is equipped to help you not only navigate them but also to accelerate clinical trials. Learn more about this through our upcoming webinar by our experts Jeffrey Keefer and Bryce Davis.

🤩 With the public availability of #PITTER, Belgium has taken another step in the personalisation of healthcare. PITwhat?? PITTER is the Belgian register for the results of "predictive tests for a therapeutic response", a.k.a. #companiondiagnostics. These lab tests predict whether a patient will benefit therapeutically from treatment with a "personalised" drug, thereby avoiding inneffective treatments and possible side effects. Everyone wins this way: 👉 #Patients receive tailored care. 👉 #Healthcareproviders can select the best therapies for their patients. 👉 Society improves the cost-effectiveness of healthcare spending. To ensure that patients have access to the right personalised therapies, it's important to gather the necessary evidence. 👀 And this is where PITTER comes into play. 4.5 years ago, laboratories began registering the results* of companion diagnostics in PITTER (* in generic terms, to ensure patient privacy). By doing so, they gather valuable epidemiological data on #biomarkers, thus supporting further personalisation of care for Belgian patients Now, the PITTER registry is publicly available! 👏 Congratulations to all laboratories, RIZIV, Sciensano, healthdata be, the cabinet of Minister Vandenbroucke, and all other experts involved for achieving this new milestone! #CDx #precisionmedicine #healthdata #diagnostics #evidencebasedmedicine #medtechmatters Anouk Waeytens https://lnkd.in/erCGfkqD

Real-world data has the potential to enhance clinical trials across all steps and phases – yet many hurdles remain before this data can be leveraged broadly. This past May, the DCRI Think Tank sat down to explore the potential of RWD and what barriers need to be overcome to make application accepted by regulators and healthcare communities. Read the full meeting brief below, and check out past Think Tank briefs and publications at: https://lnkd.in/eB8jWWu5 #clinicaltrials #clinicalresearch #realworlddata #thinktank

What are the major factors driving world healthcare dynamics? How they are impacting the overall landscape for clinical trials worldwide? Download your free report in partnership with IQVIA to find out: https://ow.ly/mAjW50SowuU. #HealthcareDynamics #ClinicalTrials #IQVIA #PharmaIndustry